Astera Labs, Inc. $ALAB Shares Acquired by Bank of Hawaii

Bank of Hawaii increased its position in Astera Labs, Inc. (NASDAQ:ALAB) by 89.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,593 shares of the company’s stock after purchasing an additional 9,721 shares during the quarter. Bank of Hawaii’s holdings in Astera Labs were worth $1,229,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Mariner LLC acquired a new position in Astera Labs in the 4th quarter worth $781,000. NewEdge Advisors LLC acquired a new stake in shares of Astera Labs during the fourth quarter valued at about $63,000. First Trust Advisors LP increased its position in shares of Astera Labs by 78.3% during the fourth quarter. First Trust Advisors LP now owns 123,901 shares of the company’s stock worth $16,411,000 after acquiring an additional 54,413 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Astera Labs by 4.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 18,250 shares of the company’s stock worth $2,417,000 after acquiring an additional 768 shares during the last quarter. Finally, MetLife Investment Management LLC lifted its stake in shares of Astera Labs by 391.3% in the fourth quarter. MetLife Investment Management LLC now owns 2,137 shares of the company’s stock worth $283,000 after acquiring an additional 1,702 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on ALAB. Roth Capital set a $100.00 price objective on Astera Labs and gave the company a “buy” rating in a research note on Wednesday, May 7th. Jefferies Financial Group increased their target price on Astera Labs from $95.00 to $130.00 and gave the company a “buy” rating in a research note on Tuesday, July 22nd. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price target for the company. in a research report on Tuesday, July 22nd. Morgan Stanley lifted their price target on shares of Astera Labs from $125.00 to $155.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 6th. Finally, William Blair started coverage on shares of Astera Labs in a research note on Thursday, May 22nd. They set an “outperform” rating on the stock. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus price target of $129.13.

Astera Labs Trading Up 0.9%

ALAB stock opened at $179.09 on Monday. The stock’s 50 day simple moving average is $123.97 and its 200 day simple moving average is $92.74. Astera Labs, Inc. has a 12-month low of $36.85 and a 12-month high of $199.47. The firm has a market cap of $29.77 billion, a P/E ratio of 319.80, a P/E/G ratio of 4.54 and a beta of 1.39.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm had revenue of $191.93 million during the quarter, compared to the consensus estimate of $172.46 million. During the same quarter in the previous year, the company posted $0.13 earnings per share. The firm’s revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Activity

In related news, CFO Michael Truett Tate sold 500,000 shares of the business’s stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $90.23, for a total transaction of $45,115,000.00. Following the completion of the sale, the chief financial officer owned 618,996 shares of the company’s stock, valued at $55,852,009.08. This represents a 44.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jitendra Mohan sold 152,517 shares of the firm’s stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the completion of the transaction, the chief executive officer directly owned 450,001 shares in the company, valued at $76,648,670.33. This represents a 25.31% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 2,385,416 shares of company stock valued at $298,063,981. Company insiders own 12.50% of the company’s stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.